数据链接：
官方服务：
资源简介：
Understand if PROTAC treatment changes the amount of MHC-I on the cell surface Conclusion: It does not.
应用场景：
创建时间：
2018-11-01
相关数据集
MAFB surrogates the glucocorticoid receptor ability to induce tolerogenesis in dendritic cells [CHIP_SEQ]
Glucocorticoids (GCs) exert potent anti-inflammatory effects in immune cells through the glucocorticoid receptor (GR). Dendritic cells (DCs), central actors for coordinating immune responses, acquire
NIAID Data Ecosystem50
CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β
Cell-surface transferrin receptor (CD71+) erythroid cells are abundant in newborns with immunomodulatory properties. Here, we show that neonatal CD71+ erythroid cells express significant levels of V-d
Figshare2018-12-28 更新30
Rational Design, Synthesis, and Biological Evaluation of Novel c‑Met Degraders for Lung Cancer Therapy
Cellular-mesenchymal epithelial transition factor (c-Met) is an attractive target for treating multiple cancers. Despite plentiful c-Met inhibitors have been developed, some issues, including the acqu
NIAID Data Ecosystem00
Schistosoma mansoni Tegument (Smteg) Induces IL-10 and Modulates Experimental Airway Inflammation
Background Previous studies have demonstrated that S. mansoni infection and inoculation of the parasite eggs and antigens are able to modulate airways inflammation induced by OVA in mice. This modulat
NIAID Data Ecosystem30
Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. Although an immune checkpoint blockade can reduce metastasis, its effectiveness is hindered by the immunosuppressi
NIAID Data Ecosystem20
